Results

• All
• Video
• Audio
• Images

• Most recent

1–2 of 2 results for SB15

• 

  Phase III Randomized Clinical Trial Comparing SB15 With Reference Aflibercept in Neovascular Age-Related Macular Degeneration 56-Week Results

  Min Sagong, MD

  Annual Meeting Talks

  2023

• 

  Assessment on Pre-to-Post Switching Efficacy and Safety of SB15 (Proposed Aflibercept Biosimilar): Post Hoc Analysis of a Phase 3 Clinical Trial

  Srinivas Reddy Sadda, MD

  Annual Meeting Talks

  2024